"SAN FRANCISCO â€” Tumor-treating fields (TTFields, Novocure) therapy, already approved for use in glioblastoma, has now shown benefit in patients with advanced pancreatic cancer.
TTFields combined with gemcitabine (Gemzar, Lill"...
AdreView Patient Information Including Side Effects
Brand Names: AdreView
Generic Name: iobenguane I-123 (Pronunciation: EYE oh BEN gwayne)
- What is iobenguane I-123 (AdreView)?
- What are the possible side effects of iobenguane I-123 (AdreView)?
- What is the most important information I should know about iobenguane I-123 (AdreView)?
- What should I discuss with my health care provider before receiving iobenguane I-123 (AdreView)?
- How is iobenguane I-123 given (AdreView)?
- What happens if I miss a dose (AdreView)?
- What happens if I overdose (AdreView)?
- What should I avoid while receiving iobenguane I-123 (AdreView)?
- What other drugs will affect iobenguane I-123 (AdreView)?
- Where can I get more information?
What is iobenguane I-123 (AdreView)?
Iobenguane I-123 is in a group of drugs called diagnostic radiopharmaceuticals (RAY dee oh far ma SOO tik als). Iobenguane I-123 is a radioactive agent that allows images of specific organs in the body to be detected by a gamma camera.
Iobenguane I-123 is used to detect certain kinds of cancer of the adrenal glands
Iobenguane I-123 may also be used for purposes not listed in this medication guide.
What are the possible side effects of iobenguane I-123 (AdreView)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects may include:
- mild skin rash or itching;
- bleeding around your IV needle; or
- warmth, tingling, or cold feeling where the medicine was injected.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the AdreView (iobenguane i 123 injection for intravenous use) Side Effects Center for a complete guide to possible side effects
What is the most important information I should know about iobenguane I-123 (AdreView)?
You should not receive this medication if you are allergic to iobenguane. Tell your doctor if you have ever had any type of reaction to another contrast agent, or to potassium.
Before you are treated with iobenguane I-123, tell your doctor if you have kidney disease, a thyroid disorder, if you are dehydrated or unable to urinate, or if you are allergic to iodine.
Tell your doctor about all other medications you are using, especially antidepressants, cold medicines, blood pressure medications, or ADHD medications. You may need to stop using certain drugs for a short time before you receive iobenguane I-123
Drink extra fluids before you receive iobenguane I-123, and for at least 48 hours afterward. Follow your doctor's instructions about the types and amount of liquids you should drink before and after your test. Iobenguane I-123 is radioactive and it can cause dangerous effects on your bladder if it is not properly eliminated from your body through urination.
Do not allow yourself to become dehydrated during the first few days after receiving iobenguane I-123. Call your doctor if you have any vomiting or diarrhea during this time. Follow your doctor's instructions about the types and amount of fluids you should drink.
Additional AdreView Information
- AdreView Drug Interactions Center: iobenguane sulfate i-123 iv
- AdreView Side Effects Center
- AdreView FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.